Breaking News Instant updates and real-time market news.

CCXI

ChemoCentryx

$7.33

-0.03 (-0.41%)

04:55
10/09/19
10/09
04:55
10/09/19
04:55

ChemoCentryx management to meet with JPMorgan

Investor Luncheon Meeting to be held in San Francisco on October 9 hosted by JPMorgan.

  • 09

    Oct

CCXI ChemoCentryx
$7.33

-0.03 (-0.41%)

06/06/19
ADAM
06/06/19
NO CHANGE
Target $14
ADAM
Buy
ChemoCentryx price target lowered to $14 from $20 at Canaccord
Canaccord analyst Michelle Gilson lowered her price target on ChemoCentryx to $14 from $20 following the failure of IFX-1 failing to validate the C5a hypothesis in HS. The analyst believes AAV (associated vasculitis) remains a better indication than HS and is central to his buy thesis. Gilson maintained her Buy rating on ChemoCentryx shares.
06/06/19
RAJA
06/06/19
NO CHANGE
Target $17
RAJA
Strong Buy
ChemoCentryx price target lowered to $17 from $24 at Raymond James
Raymond James analyst Steven Seedhouse removed hidradenitis suppurativa from his model for ChemoCentryx (CCXI) after InflaRx (IFRX) reported that its Phase IIb trial for C5a antibody IFX-1 failed, leading him to lower his price target on the shares to $17 from $24. However, he keeps a Strong Buy rating on ChemoCentryx shares and said he would be a buyer amid the weakness, citing Phase 2 data for avacopan in AAV and a near-term Phase 3 data readout for AAV in Q4.
09/12/19
JPMS
09/12/19
UPGRADE
Target $14
JPMS
Overweight
ChemoCentryx upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Anupam Rama upgraded ChemoCentryx to Overweight from Neutral with a price target of $14, down from $16. The analyst sees a favorable risk/reward profile at current share levels.
09/12/19
JPMS
09/12/19
UPGRADE
Target $14
JPMS
Overweight
JPMorgan upgrades ChemoCentryx to Overweight ahead of Phase 3 readout
JPMorgan analyst Anupam Rama upgraded ChemoCentryx to Overweight from Neutral with a price target of $14, down from $16. Following a round of key opinion leader and physician discussions, the analyst believes the Phase 3 Advocate study of avacopan in associated vasculitis has a high probability of success. The share pressure dating back to the spring has created a favorable risk/reward scenario for shares of ChemoCentryx ahead of the Phase 3 results, Rama tells investors in a research note. The analyst expects the readout in the mid-to-late Q4 timeframe.

TODAY'S FREE FLY STORIES

FB

Facebook

$184.34

2.07 (1.14%)

11:05
10/23/19
10/23
11:05
10/23/19
11:05
Hot Stocks
Facebook shares up 1.6% as CEO testifies on Capitol Hill »

Facebook CEO Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

CNC

Centene

$48.49

-0.28 (-0.57%)

11:05
10/23/19
10/23
11:05
10/23/19
11:05
Options
Centene call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

D

Dominion

$83.07

0.29 (0.35%)

11:03
10/23/19
10/23
11:03
10/23/19
11:03
Hot Stocks
Dominion, Smithfield Foods double investment in renewable natural gas to $500M »

Dominion Energy and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

BA

Boeing

$345.52

8.07 (2.39%)

11:02
10/23/19
10/23
11:02
10/23/19
11:02
Hot Stocks
Boeing CFO says it will take 'several quarters' to deliver parked 737 MAX jets »

CFO Greg Smith says it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$345.79

8.34 (2.47%)

11:00
10/23/19
10/23
11:00
10/23/19
11:00
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing says studying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

MMM

3M

$166.93

-0.63 (-0.38%)

10:55
10/23/19
10/23
10:55
10/23/19
10:55
Options
3M put volume heavy and directionally bearish »

Bearish flow noted in 3M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GLOG

GasLog

$14.29

0.325 (2.33%)

, GLOP

GasLog Partners

$20.24

0.35 (1.76%)

10:55
10/23/19
10/23
10:55
10/23/19
10:55
Conference/Events
Deutsche Bank shipping analyst to hold analyst/industry conference call »

Analysts, along with…

GLOG

GasLog

$14.29

0.325 (2.33%)

GLOP

GasLog Partners

$20.24

0.35 (1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 30

    Oct

  • 06

    Nov

BA

Boeing

$346.26

8.81 (2.61%)

10:54
10/23/19
10/23
10:54
10/23/19
10:54
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$346.90

9.45 (2.80%)

10:53
10/23/19
10/23
10:53
10/23/19
10:53
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing sees first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

FCX

Freeport McMoRan

$9.98

0.06 (0.60%)

10:51
10/23/19
10/23
10:51
10/23/19
10:51
Hot Stocks
Freeport McMoRan says current copper prices not sustainable »

Management said the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$347.23

9.78 (2.90%)

10:50
10/23/19
10/23
10:50
10/23/19
10:50
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing: US-China trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

UXIN

Uxin

$2.68

-0.04 (-1.47%)

10:47
10/23/19
10/23
10:47
10/23/19
10:47
Downgrade
Uxin rating change  »

JPMorgan downgrades Uxin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$348.24

10.79 (3.20%)

10:43
10/23/19
10/23
10:43
10/23/19
10:43
Hot Stocks
Boeing CEO says may consider further 737 rate reductions, line shutdown »

Says should the estimate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$348.52

11.07 (3.28%)

10:41
10/23/19
10/23
10:41
10/23/19
10:41
Hot Stocks
Boeing expects to maintain current production rate for 737 MAX »

Expects to maintain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

KRE

SPDR S&P Regional Banking ETF

$53.96

-0.2 (-0.37%)

10:40
10/23/19
10/23
10:40
10/23/19
10:40
Options
Size put spread in Regional Banking ETF rolls long puts to higher strike »

Size put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
10/23/19
10/23
10:40
10/23/19
10:40
General news
Energy Action: WTI crude »

Energy Action: WTI crude…

BA

Boeing

$349.46

12.01 (3.56%)

10:37
10/23/19
10/23
10:37
10/23/19
10:37
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$349.60

12.15 (3.60%)

10:36
10/23/19
10/23
10:36
10/23/19
10:36
Hot Stocks
Boeing: FAA, others will ultimately determine timing of MAX return to service »

Says return to service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$349.40

11.95 (3.54%)

10:35
10/23/19
10/23
10:35
10/23/19
10:35
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing says sees approval…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HOG

Harley-Davidson

$39.46

-0.57 (-1.42%)

10:35
10/23/19
10/23
10:35
10/23/19
10:35
Options
Harley Davidson put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
10/23/19
10/23
10:35
10/23/19
10:35
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

BA

Boeing

$349.81

12.36 (3.66%)

10:35
10/23/19
10/23
10:35
10/23/19
10:35
Hot Stocks
Boeing says has conducted more than 800 tests in production flights »

Says has conducted more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$349.65

12.2 (3.62%)

10:34
10/23/19
10/23
10:34
10/23/19
10:34
Hot Stocks
Boeing CEO says 'regrets' difficulties that release of IM document has presented »

Says "understands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$349.52

12.07 (3.58%)

10:33
10/23/19
10/23
10:33
10/23/19
10:33
Hot Stocks
Boeing CEO says 737 MAX accidents 'weigh heavily on us' »

Sys "nothing is more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

USO

United States Oil Fund

$11.37

0.025 (0.22%)

10:30
10/23/19
10/23
10:30
10/23/19
10:30
General news
Crude inventories for week of October 18 »

Crude oil inventories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.